Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» January 2011
January 2011
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Mylan
Matrixx
HIV
antiretrovirals
Tibotec
TMC278
Glaxo Settles U.S. Federal Avandia Drug Case
Glaxo Settles U.S. Federal Avandia Drug Case
WSJ
GSK
Avandia
lawsuits
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
Bloomberg
MorphoSys
Pfizer
OncoMed
Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
Yahoo/PR NewsWire
Savient
Vanda Pharmaceuticals Files Shelf Registration Statement
Vanda Pharmaceuticals Files Shelf Registration Statement
Yahoo/PR NewsWire
Vanda
stock offering
Repligen Announces Conference Call of Third Quarter Fiscal Year 2011 Results
Repligen Announces Conference Call of Third Quarter Fiscal Year 2011 Results
BusinessWire
Repligen
earnings
Genzyme, Sanofi-Aventis Reach Confidentiality Agreement, SEC Filing Shows
Genzyme, Sanofi-Aventis Reach Confidentiality Agreement, SEC Filing Shows
Bloomberg
Genzyme
Sanofi
M&A
NPS Pharma: Gattex Bowel Study Succeeds
NPS Pharma: Gattex Bowel Study Succeeds
The Street
NPS Pharmaceuticals
Gattex
short bowel syndrome
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Yahoo/PR NewsWire
Inovio
acute myeloid leukemia
chronic myeloid leukemia
leukemia
Elgen 1000
cancer vaccines
Sanofi-Aventis' Most Promising Clinical Candidate Takes a Nasty Fall
Sanofi-Aventis' Most Promising Clinical Candidate Takes a Nasty Fall
Seeking Alpha
Sanofi
iniparib
breast cancer
Parp inhibition
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »